Onderneming AstraZeneca Pharma India Limited
Aandelen
ASTRAZEN
INE203A01020
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5.415 INR | +1,53% | +4,70% | -1,89% |
Vakgebied
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Tablets
75,2
%
| 6 491 | 80,6 % | 7 543 | 75,2 % | +16,21% |
Injectables
16,7
%
| 937 | 11,6 % | 1 674 | 16,7 % | +78,56% |
Clinical Trials
6,1
%
| 442 | 5,5 % | 612 | 6,1 % | +38,57% |
Inhalation
2,0
%
| 186 | 2,3 % | 201 | 2,0 % | +8,06% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
India
93,6
%
| 7 592 | 94,2 % | 9 389 | 93,6 % | +23,68% |
International
6,4
%
| 464 | 5,8 % | 641 | 6,4 % | +37,95% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Siva Padmanabhan
CEO | Chief Executive Officer | - | - |
Sanjeev Panchal
CEO | Chief Executive Officer | - | 01-02-03 |
Bhavana Agrawal
DFI | Director of Finance/CFO | - | 01-10-23 |
Anil Kukreja
CTO | Chief Tech/Sci/R&D Officer | - | - |
Manasa Rama
CMP | Compliance Officer | - | 11-08-22 |
Hooi-Bien Chuah
BRD | Director/Board Member | - | 01-04-21 |
Pankaj Jain
LAW | General Counsel | - | - |
Rishi Kapur
LAW | General Counsel | - | - |
Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Revathy Ashok
BRD | Director/Board Member | 65 | 02-12-16 |
Chairman | 67 | 06-12-12 | |
Director/Board Member | 50 | 29-12-21 | |
Ankush Nandra
BRD | Director/Board Member | 52 | 18-05-20 |
Sanjeev Panchal
CEO | Chief Executive Officer | - | 01-02-03 |
Bhavana Agrawal
DFI | Director of Finance/CFO | - | 01-10-23 |
Hooi-Bien Chuah
BRD | Director/Board Member | - | 01-04-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 25 000 000 | 3 106 045 ( 12,42 %) | 0 | 12,42 % |
Bedrijfsgegevens
AstraZeneca Pharma India Ltd.
Manyata Embassy Business Park Outer Ring Road, Rachenahalli
560045, Bangalore
+91 80 6774 8000
http://www.astrazeneca.inSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,89% | 1,62 mld. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers ASTRAZEN
- Onderneming AstraZeneca Pharma India Limited